SCHEMBL14786950

SCHEMBL14786950

C#CC(=O)N(CC(N)=O)c1ccc(OC)cc1C

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 6/20 0.39
▸ NFE2L2 Q16236 6/20 0.39
▸ HTT P42858 1/20 0.37
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MTNR1B P49286 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MTNR1A P48039 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ PLA2G2A P14555 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14788609 0.87 GAA (0.43) KEAP1NFE2L2HTTALDH1A1HPGD
SCHEMBL3604278 0.69 POLB (0.42) KEAP1NFE2L2HTTKDM4ETSHR
SCHEMBL12696372 0.69 ATM (0.45) HTTALDH1A1HPGDMEN1KMT2A
SCHEMBL14788566 0.67 MEN1 (0.66) ALDH1A1HPGDMAPTL3MBTL1MEN1
SCHEMBL23139862 0.67 HTT (0.56) KEAP1NFE2L2HTTKDM4EALDH1A1
SCHEMBL2205243 0.67 LMNA (0.48) KEAP1NFE2L2HTTKDM4EALDH1A1
SCHEMBL22939500 0.67 LMNA (0.48) KEAP1NFE2L2HTTALDH1A1HPGD
SCHEMBL29607987 0.67 HTT (0.56) KEAP1NFE2L2HTTKDM4EALDH1A1
SCHEMBL8809964 0.65 KMT2A (0.43) KEAP1NFE2L2HTTKDM4EALDH1A1
SCHEMBL14925281 0.65 KMT2A (0.46) KEAP1NFE2L2HTTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130071328-A1 Propynoic Acid Carbamoyl Methyl-Amides and Pharmaceutical Compositions and Methods Based Thereon UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130071328-A1 Propynoic Acid Carbamoyl Methyl-Amides and Pharmaceutical Compositions and Methods Based Thereon RELA, NFE2, NCOA1 KEAP1 20/4885NFE2L2 4/4885HTT 1349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback